Navigation Links
New Federal Stem Cell Rules Would Hinder Existing Research, Consumer Group Warns
Date:5/20/2009

NIH Should Fix Standards to Allow Use of Current Stem Cell Lines

SANTA MONICA, Calif., May 20 /PRNewswire-USNewswire/ -- -- Regulations governing stem cell research proposed by the Obama Administration -- unless modified before final implementation on July 1 -- prohibit federal funding of important research that had received funding under the Bush Administration, Consumer Watchdog said today. The nonpartisan, nonprofit group called on the National Institutes of Health to change the draft regulations.

On March 9, President Obama signed an executive order intended to lift restrictions on federal funding of human embryonic stem cell research. As part of the order, the National Institutes of Health (NIH) were directed to develop regulations "to help ensure that NIH-funded research in this area is ethically responsible, scientifically worthy, and conducted in accordance with applicable law."

"Most of us were heartened when President Obama lifted Bush Administration restrictions on funding stem cell research, but the perverse effect of these proposed NIH rules is that the limited research scientists were able to conduct under Bush will now be ineligible for federal funding," said John M. Simpson, Consumer Watchdog's Stem Cell Project Director. "Certainly this is not what President Obama intended and the regulations must be modified."

Bush allowed the NIH to fund research on embryonic stem cell lines that were derived before 9 pm, Aug. 9, 2001. In practice there were about 20 lines that were available to scientists that qualified for federal money. Embryonic stem cells, which have the potential to develop into virtually any cell in the body, are derived from embryos left over from in vitro fertilization (IVF) treatments and would otherwise be destroyed.

The Bush approved stem cell lines were derived before the proposed NIH rules and do not meet some of their specific technical standards. In addition some stem cell lines derived with state or private funding or in other countries since 2001 don't meet some of the technical specifications of the proposed NIH rules.

For instance, under the new NIH guidelines donors would have to be told that the embryos would be used for stem cell research. When some of the earlier lines were derived, donors were told more generically that the embryos would be used for research. The new regulations call for an explicit statement that the results of using the human embryonic stem cells may have commercial potential and that the donor would not receive any financial benefit from such commercial development. They also would have to be told that the stem cell lines derived from the donated embryos might be maintained for many years.

"The NIH guidelines set the highest standards and make sense going forward," said Simpson. "However the earlier lines were derived under Institutional Review Board (IRB) supervision, following ethical guidelines then in place, suggested by such organizations as the National Academies of Science, or covered by state regulations like those of the California Institute of Regenerative Medicine. It would be wrong to preclude them from federal funding going forward. You can't hold someone to standards that didn't exist when these lines were derived in good faith according to then existing standards."

Consumer Watchdog supports modifications proposed by the California Institute for Regenerative Medicine (CIRM) and suggestions raised by the Interstate Alliance on Stem Cell Research.

The draft NIH regulations are open for public comment until May 26. Comments may be made on line here: http://nihoerextra.nih.gov/stem_cells/add.htm .

Read the proposed regulations here: http://edocket.access.gpo.gov/2009/E9-9313.htm

Read CIRM's comments here: http://www.cirm.ca.gov/sites/default/files/NIH%20Comments%20NIH_guidelines%20v12_5_14.pdf

Read the Interstate Alliance on Stem Cell Research discussion of the regulations here: http://www.iascr.org/docs/May2009/IASCR_Summary_NIH_Discussion.pdf

Consumer Watchdog, formerly the Foundation for Taxpayer and Consumer Rights is a nonprofit, nonpartisan organization with offices in Washington, DC and Santa Monica, Ca. Our website is www.consumerwatchdog.org .


'/>"/>
SOURCE Consumer Watchdog
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. State, Federal Officials Remind Health Care Workers, Other at-Risk Individuals to Get Annual Flu Shot
2. Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates
3. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
4. Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing
5. A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe
6. A Drug With Efficacy Superior to That of Xenical at Inducing Weight Loss Would Earn a 40 Percent Patient Share in the Obesity Drug Market
7. Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine
8. Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib)
9. CoAxia(TM) Announces $11.5M Equity Financing From Existing Investors
10. Lions Eye Institute for Transplant & Research, Inc. Launches Multi-Million Dollar, State-of-the-Art Research Institute that Will Advance the Study of Blinding Eye Diseases
11. Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... February 12, 2016 ... auf den ungedeckten medizinischen Bedarf bei Lungen- ... seines klinischen Forschungsprogramms bekannt. Das Programm, das ... Verbesserungen ihrer respiratorischen Funktionen und anderer klinischer ... ein Medizintechnikunternehmen, das sich auf den ungedeckten ...
(Date:2/11/2016)... Feb. 11, 2016 PRO-DEX, INC. (NasdaqCM: PDEX) today ... December 31, 2015. The Company also filed its Quarterly Report ... 2016 with the Securities and Exchange Commission today. ... 2015 --> --> Net ... $2.6 million, or 95%, to $5.4 million from $2.8 million ...
(Date:2/11/2016)... 2016   Health 2.0 , the premiere showcase ... announced today " 10 Year Global Retrospective ", a ... the past ten years.   --> ... 2.0 has served as the preeminent thought-leader in the ... of technologies, companies, innovators, and patient-activists through an array ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... ... DDi , a Makro company, makes it to ... in eClinical Solutions. DDi has built its solution competency with a unique blend ... DDi provides smarter technology for Clinical Development, Regulatory and Enterprise domains by providing ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Lymphoma ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... South Florida’s philanthropic community at its 10th anniversary Fashion Luncheon on Monday, February ...
(Date:2/12/2016)... ... February 12, 2016 , ... Coco Libre, the maker of ... Carpet Events LA GRAMMY’s Style Lounge Event. Coco Libre will offer musicians and celebrities ... before the big event. The invitation-only gifting suite, held this year at the W ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fisher House Foundation Chairman and ... J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy Kearns Director, VA ... Southern Nevada Healthcare System. This will be the first Fisher House in Nevada, ...
(Date:2/12/2016)... Pittsburgh, PA (PRWEB) , ... February 12, 2016 ... ... serving families of the Pittsburgh metro area, celebrates the beginning of the latest ... help children develop social skills through art. Donations to this worthy cause are ...
Breaking Medicine News(10 mins):